Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9.6M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 1 filing we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Aug 4 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 27,567 | — | — | — | Open the original filing on SEC.gov |
| Aug 4 | ELVN | Enliven Therapeutics, Inc. | MEXER◷◆ | 87,373 | — | — | — | Open the original filing on SEC.gov |
| Aug 4 | ELVN | Enliven Therapeutics, Inc. | SSELL◷ | 158,795 | $60.21 | $9.6M | -100.0% | Open the original filing on SEC.gov |
| Aug 4 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 20,491 | $22.47 | $460.4K | +14.8% | Open the original filing on SEC.gov |
| Aug 4 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 23,364 | $14.85 | $347K | +20.3% | Open the original filing on SEC.gov |
| Aug 4 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 27,567 | $25.28 | $696.9K | +31.6% | Open the original filing on SEC.gov |
| Aug 4 | ELVN | Enliven Therapeutics, Inc. | MEXER◷ | 87,373 | $2.48 | $216.7K | — | Open the original filing on SEC.gov |